open access

Ahead of print
Review Papers
Published online: 2019-07-02
Get Citation

The purpose of electrocardiography in acute and chronic diseases with right ventricular involvement

Joanna Radochońska, Monika Lisicka, Piotr Bienias
DOI: 10.5603/FC.a2019.0089

open access

Ahead of print
Review Papers
Published online: 2019-07-02

Abstract

Electrocardiography is a basic diagnostic tool and plays a significant role in differentiating many diseases, including those involving right heart. The diagnosis of right ventricular pathology is difficult due to the complex structure and the wide spectrum of hemodynamic disorders resulting from its dysfunction. The use of standard electrocardiogram with right-sided leads may be valuable complement of imaging tests especially if these are not quickly available. Numerous of electrocardiographic abnormalities are observed in the course of acute pulmonary embolism, chronic pulmonary hypertension, right ventricular myocardial infarction or arrhythmogenic right ventricular cardiomyopathy and some of them have also prognostic significance. Unfortunately, despite its simplicity and utility, electrocardiogram is characterized by an insufficient sensitivity and specificity to be a single tool in the recognition of the right ventricle pathologies. Electrocardiogram is a common, inexpensive, non-invasive and easy to accomplish complementary test, which can be useful in diagnostic algorithm of the right heart diseases.

Abstract

Electrocardiography is a basic diagnostic tool and plays a significant role in differentiating many diseases, including those involving right heart. The diagnosis of right ventricular pathology is difficult due to the complex structure and the wide spectrum of hemodynamic disorders resulting from its dysfunction. The use of standard electrocardiogram with right-sided leads may be valuable complement of imaging tests especially if these are not quickly available. Numerous of electrocardiographic abnormalities are observed in the course of acute pulmonary embolism, chronic pulmonary hypertension, right ventricular myocardial infarction or arrhythmogenic right ventricular cardiomyopathy and some of them have also prognostic significance. Unfortunately, despite its simplicity and utility, electrocardiogram is characterized by an insufficient sensitivity and specificity to be a single tool in the recognition of the right ventricle pathologies. Electrocardiogram is a common, inexpensive, non-invasive and easy to accomplish complementary test, which can be useful in diagnostic algorithm of the right heart diseases.

Get Citation

Keywords

electrocardiography; pulmonary embolism; pulmonary hypertension; right ventricle infarction; arrhythmogenic right ventricular cardiomyopathy

About this article
Title

The purpose of electrocardiography in acute and chronic diseases with right ventricular involvement

Journal

Folia Cardiologica

Issue

Ahead of print

Published online

2019-07-02

DOI

10.5603/FC.a2019.0089

Keywords

electrocardiography
pulmonary embolism
pulmonary hypertension
right ventricle infarction
arrhythmogenic right ventricular cardiomyopathy

Authors

Joanna Radochońska
Monika Lisicka
Piotr Bienias

References (44)
  1. Schmitto JD, Doerge H, Post H, et al. Progressive right ventricular failure is not explained by myocardial ischemia in a pig model of right ventricular pressure overload. Eur J Cardiothorac Surg. 2009; 35(2): 229–234.
  2. Bienias P, Rymarczyk Z. Badanie elektrokardiograficzne w zatorowości płucnej. In: Pruszczyk P, Ciurzyński M, Kostrubiec M. ed. Żylna choroba zakrzepowo-zatorowa. Medical Tribune Polska, Warszawa 2012: 68–74.
  3. Stein PD, Dalen JE, McIntyre KM, et al. The electrocardiogram in acute pulmonary embolism. Prog Cardiovasc Dis. 1975; 17(4): 247–257.
  4. Kukla P, Długopolski R, Krupa E, et al. How often pulmonary embolism mimics acute coronary syndrome? Kardiol Pol. 2011; 69(3): 235–240.
  5. Kukla P, Dlugopolski R, Krupa E, et al. The prognostic value of ST-segment elevation in the lead aVR in patients with acute pulmonary embolism. Kardiol Pol. 2011; 69(7): 649–654.
  6. Kukla P, Długopolski R, Krupa E, et al. Electrocardiography and prognosis of patients with acute pulmonary embolism. Cardiol J. 2011; 18(6): 648–653.
  7. Kukla P, McIntyre WF, Fijorek K, et al. T-wave inversion in patients with acute pulmonary embolism: prognostic value. Heart Lung. 2015; 44(1): 68–71.
  8. Qaddoura A, Digby GC, Kabali C, et al. The value of electrocardiography in prognosticating clinical deterioration and mortality in acute pulmonary embolism: A systematic review and meta-analysis. Clin Cardiol. 2017; 40(10): 814–824.
  9. Zhong-Qun Z, Chong-Quan W, Nikus KC, et al. A new electrocardiogram finding for massive pulmonary embolism: ST elevation in lead aVR with ST depression in leads I and V(4) to V(6). Am J Emerg Med. 2013; 31(2): 456.e5–456.e8.
  10. Casazza F, Pacchetti I, Rulli E, et al. Prognostic significance of electrocardiogram at presentation in patients with pulmonary embolism of different severity. Thromb Res. 2018; 163: 123–127.
  11. Daniel KR, Courtney DM, Kline JA. Assessment of cardiac stress from massive pulmonary embolism with 12-lead ECG. Chest. 2001; 120(2): 474–481.
  12. Toosi MS, Merlino JD, Leeper KV. Electrocardiographic score and short-term outcomes of acute pulmonary embolism. Am J Cardiol. 2007; 100(7): 1172–1176.
  13. Kostrubiec M, Hrynkiewicz A, Pedowska-Włoszek J, et al. Is it possible to use standard electrocardiography for risk assessment of patients with pulmonary embolism? Kardiol Pol. 2009; 67(7): 744–750.
  14. Hariharan P, Dudzinski DM, Okechukwu I, et al. Association between electrocardiographic findings, right heart strain, and short-term adverse clinical events in patients with acute pulmonary embolism. Clin Cardiol. 2015; 38(4): 236–242.
  15. Das MK, Khan B, Jacob S, et al. Significance of a fragmented QRS complex versus a Q wave in patients with coronary artery disease. Circulation. 2006; 113(21): 2495–2501.
  16. Qaddoura A, Digby GC, Kabali C, et al. Use of fragmented QRS in prognosticating clinical deterioration and mortality in pulmonary embolism: A meta-analysis. Ann Noninvasive Electrocardiol. 2018; 23(5): e12552.
  17. Park SJ, Kwon CH, Bae BJ, et al. Diagnostic value of the corrected QT difference between leads V1 and V6 in patients with acute pulmonary thromboembolism. Medicine (Baltimore). 2017; 96(43): e8430.
  18. Jankowski K, Kostrubiec M, Ozdowska P, et al. Electrocardiographic differentiation between acute pulmonary embolism and non-ST elevation acute coronary syndromes at the bedside. Ann Noninvasive Electrocardiol. 2010; 15(2): 145–150.
  19. Omar HR, Mangar D, Camporesi EM. Acute pulmonary embolism masquerading as inferior myocardial infarction. Am J Emerg Med. 2015; 33(4): 580–581.
  20. Kosuge M, Kimura K, Ishikawa T, et al. Electrocardiographic differentiation between acute pulmonary embolism and acute coronary syndromes on the basis of negative T waves. Am J Cardiol. 2007; 99(6): 817–821.
  21. Kozaci N, Ay MO, Beydilli I, et al. Right-sided electrocardiogram usage in acute pulmonary embolism. Am J Emerg Med. 2016; 34(8): 1437–1441.
  22. Kopec G, Tyrka A, Miszalski-Jamka T, et al. Electrocardiogram for the Diagnosis of Right Ventricular Hypertrophy and Dilation in Idiopathic Pulmonary Arterial Hypertension. Circulation Journal. 2012; 76(7): 1744–1749.
  23. Miura M, Ikeda S, Yoshida T, et al. Deeper S Wave in Lead V5 and Broader Extent of T Wave Inversions in the Precordial Leads are Clinically Useful Electrocardiographic Parameters for Predicting Pulmonary Hypertension. Int Heart J. 2018; 59(1): 136–142.
  24. Sun PY, Jiang X, Gomberg-Maitland M, et al. Prolonged QRS duration: a new predictor of adverse outcome in idiopathic pulmonary arterial hypertension. Chest. 2012; 141(2): 374–380.
  25. Rich JD, Thenappan T, Freed B, et al. QTc prolongation is associated with impaired right ventricular function and predicts mortality in pulmonary hypertension. Int J Cardiol. 2013; 167(3): 669–676.
  26. Waligóra M, Kopeć G, Jonas K, et al. Mechanism and prognostic role of qR in V in patients with pulmonary arterial hypertension. J Electrocardiol. 2017; 50(4): 476–483.
  27. Lang I. Chronic thromboembolic pulmonary hypertension: a distinct disease entity. Eur Respir Rev. 2015; 24(136): 246–252.
  28. Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J. 2009; 30(20): 2493–2537.
  29. Lewczuk J, Ajlan A, Piszko P, et al. Electrocardiographic signs of right ventricular overload in patients who underwent pulmonary embolism event(s). Are they useful in diagnosis of chronic thromboembolic pulmonary hypertension? J Electrocardiol. 2004; 37(3): 219–225.
  30. Klok FA, Surie S, Kempf T, et al. A simple non-invasive diagnostic algorithm for ruling out chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. Thromb Res. 2011; 128(1): 21–26.
  31. Goldstein JA. Pathophysiology and management of right heart ischemia. J Am Coll Cardiol. 2002; 40(5): 841–853.
  32. Cabin HS, Clubb KS, Wackers FJ, et al. Right ventricular myocardial infarction with anterior wall left ventricular infarction: an autopsy study. Am Heart J. 1987; 113(1): 16–23.
  33. Nagam MR, Vinson DR, Levis JT. ECG Diagnosis: Right Ventricular Myocardial Infarction. Perm J. 2017; 21: 16–105.
  34. Geft IL, Shah PK, Rodriguez L, et al. ST elevations in leads V1 to V5 may be caused by right coronary artery occlusion and acute right ventricular infarction. Am J Cardiol. 1984; 53(8): 991–996.
  35. Zehender M, Kasper W, Kauder E, et al. Right ventricular infarction as an independent predictor of prognosis after acute inferior myocardial infarction. N Engl J Med. 1993; 328(14): 981–988.
  36. Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J. 2010; 31(7): 806–814.
  37. Jain R, Dalal D, Daly A, et al. Electrocardiographic features of arrhythmogenic right ventricular dysplasia. Circulation. 2009; 120(6): 477–487.
  38. Batchvarov VN, Bastiaenen R, Postema PG, et al. Novel electrocardiographic criteria for the diagnosis of arrhythmogenic right ventricular cardiomyopathy. Europace. 2016; 18(9): 1420–1426.
  39. Fontaine G, Guiraudon G, Frank R. Stimulation studies and epicardial mapping in ventricular tachycardia: study of mechanisms and selection for surgery. In: Kulbertus HE. ed. Reentrant Arrhythmias. University Park Press, Baltimore 1977: 334–350.
  40. Biernacka EK, Platonov PG, Fronczak A. Should epsilon wave be considered as a major diagnostic criterion in arrhythmogenic right ventricular cardiomyopathy? Kardiol Pol. 2017; 75(3): 191–195.
  41. Peters S. Clinical importance of lead aVR in arrhythmogenic cardiomyopathy. Int J Cardiol. 2014; 176(2): 508–509.
  42. Peters S. Prognostic value of epsilon waves in lead aVR in arrhythmogenic cardiomyopathy. Int J Cardiol. 2015; 191: 77–78.
  43. Otsuka Y, Satomi K, Nakajima I, et al. Electrocardiographic analysis of arrhythmogenic right ventricular cardiomyopathy: cardiovascular events and the epsilon wave. Circulation. 2013(128Suppl): A16060.
  44. Walczak F, Włodarska EK, Borowiecka E, et al. Microvolt potentials in patients with arrhythmogenic dysplasia of the right ventricle. Kardiol Pol. 1988; 31(11): 719–726.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl